Sunshine Biopharma Inc. SEC filings SBFM
Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Oct 27, 2026 | Oct 30, 2026 |
| PRE 14C | Preliminary information statement | Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2026 | Oct 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 13, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 9, 2026 | Oct 8, 2026 |
| 424B4 | Prospectus | Oct 9, 2026 | — |
| EFFECT | Filing | Oct 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 5, 2026 | — |
| S-1 | Registration statement | Oct 2, 2026 | — |
| DEF 14C | Information statement | Sep 28, 2026 | Sep 15, 2026 |
| DRS | Filing | Sep 24, 2026 | — |
| PRE 14C | Preliminary proxy | Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 11, 2026 |
| EFFECT | Filing | Sep 8, 2026 | — |
| 424B3 | Prospectus | Sep 8, 2026 | — |
| S-1 | Registration statement | Aug 28, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 11, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 424B5 | Prospectus supplement | Jul 20, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 10, 2026 | Jul 8, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 8, 2026 | — |
| DEF 14C | Information statement | Jun 8, 2026 | Jun 8, 2026 |
| PRE 14C | Preliminary information statement | May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 22, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 21, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2026 | May 18, 2026 |
| 424B4 | Prospectus | May 19, 2026 | — |
| EFFECT | Filing | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 14, 2026 | — |
| CORRESP | Letter to the SEC | May 14, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| S-1 | Registration statement | May 12, 2026 | — |
| UPLOAD | Letter from the SEC | May 4, 2026 | — |
| DRSLTR | Filing | Apr 28, 2026 | — |
| DRS | Filing | Apr 28, 2026 | — |
| 4 | Insider transaction | Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2026 | Apr 6, 2026 |
| 10-K | Annual report | Apr 3, 2026 | Dec 31, 2025 |
| NT 10-K | Extension | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 9, 2026 | Mar 6, 2026 |
| DEF 14C | Information statement | Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Feb 20, 2026 | Feb 18, 2026 |
| PRE 14C | Preliminary information statement | Feb 20, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 12, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Oct 23, 2025 | — |
| DEF 14A | Proxy statement | Oct 23, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Auditor change
|
Sep 30, 2025 | Sep 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| RW | Form rw | Aug 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2025 | — |
| CORRESP | Letter to the SEC | Aug 11, 2025 | — |
| S-1 | Registration statement | Aug 5, 2025 | — |
| POS AM | Post-effective amendment #2 | Jul 25, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 23, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 19, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 11, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 3, 2025 | Apr 2, 2025 |
| 424B5 | Prospectus supplement | Apr 3, 2025 | — |
| 8-K |
Current report
Results of operations
|
Apr 2, 2025 | Apr 1, 2025 |
| 10-K | Annual report | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 3 | Initial insider ownership | Jan 21, 2025 | Jan 13, 2025 |
| EFFECT | Filing | Jan 15, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2025 | Jan 13, 2025 |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2025 | — |
| S-3 | Shelf registration | Jan 6, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2024 | Dec 10, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 424B4 | Prospectus | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 6, 2024 |
| POS AM | Filing | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2024 | Oct 21, 2024 |
| DEF 14A | Proxy statement | Oct 17, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 9, 2024 |
| 10-Q/A | Amended quarterly report | Aug 20, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 19, 2024 | Aug 19, 2024 |
| 10-Q | Quarterly report | Aug 16, 2024 | Jun 30, 2024 |
| NT 10-Q | Request for extension | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 12, 2024 | Aug 7, 2024 |
| DEF 14C | Information statement | Jul 11, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2024 | Jun 28, 2024 |
| PRE 14C | Form pre 14c | Jul 1, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 22, 2024 | May 21, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Extension | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Auditor change
|
May 8, 2024 | May 7, 2024 |
| 8-K |
Current report
Auditor change
|
May 6, 2024 | May 3, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 23, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| DEF 14C | Information statement | Mar 15, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Shareholder vote results
|
Mar 6, 2024 | Mar 4, 2024 |
| PRE 14C | Preliminary information statement | Mar 5, 2024 | Mar 5, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 4, 2024 |
| DEF 14C | Information statement | Mar 5, 2024 | Mar 8, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 1, 2024 | Feb 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 21, 2024 | — |
| PRE 14C | Filing | Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Feb 16, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 15, 2024 | Feb 13, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 424B4 | Prospectus | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 12, 2024 | — |
| 4 | Insider transaction | Feb 12, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2024 | Feb 11, 2024 |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| S-1/A | Amended registration statement | Feb 9, 2024 | — |
| 3 | Initial insider ownership | Feb 9, 2024 | Jan 26, 2024 |
| UPLOAD | Letter from the SEC | Feb 6, 2024 | — |
| S-1 | Registration statement | Feb 1, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2024 | Jan 25, 2024 |
| S-8 | Employee stock plan registration | Jan 8, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 7, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Agreement ended
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 20, 2023 | Oct 18, 2023 |
| DEFA14A | Additional proxy material | Oct 19, 2023 | — |
| DEF 14A | Proxy statement | Oct 18, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Other events
|
Sep 22, 2023 | Sep 21, 2023 |
| DEF 14A | Proxy statement | Sep 5, 2023 | Oct 12, 2023 |
| UPLOAD | Letter from the SEC | Aug 29, 2023 | — |
| PRE 14A | Preliminary proxy statement | Aug 25, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| CORRESP | Letter to the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2023 | — |
| EFFECT | Filing | Jun 5, 2023 | — |
| 424B3 | Prospectus | Jun 5, 2023 | — |
| CORRESP | Letter to the SEC | Jun 1, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2023 | — |
| S-3 | Shelf registration | May 25, 2023 | — |
| D | Filing | May 17, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 16, 2023 | May 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| PRE 14A | Preliminary proxy statement | May 2, 2023 | May 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 19, 2023 | Apr 17, 2023 |
| 10-K | Annual report | Apr 4, 2023 | Dec 31, 2022 |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 24, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 28, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 10, 2023 | Feb 7, 2023 |
| 8-K/A | Amended current report | Dec 12, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2022 | Dec 6, 2022 |
| 4 | Insider transaction | Dec 2, 2022 | Nov 30, 2022 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| SC 13G | Ownership over 5% (passive) | Nov 2, 2022 | — |
| 3 | Initial insider ownership | Oct 26, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 20, 2022 | Oct 20, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 3, 2022 |
| EFFECT | Filing | May 20, 2022 | — |
| 424B3 | Prospectus | May 20, 2022 | — |
| CORRESP | Letter to the SEC | May 18, 2022 | — |
| UPLOAD | Letter from the SEC | May 18, 2022 | — |
| S-3 | Shelf registration | May 10, 2022 | — |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| D | Filing | Apr 29, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 28, 2022 | Apr 25, 2022 |
| EFFECT | Filing | Apr 8, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 8, 2022 |
| 424B3 | Prospectus | Apr 8, 2022 | — |
| CORRESP | Letter to the SEC | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2022 | — |
| S-3 | Shelf registration | Mar 30, 2022 | — |
| 8-K |
Current report
Other events
|
Mar 24, 2022 | Mar 24, 2022 |
| 10-K | Annual report | Mar 21, 2022 | Dec 31, 2021 |
| D | Filing | Mar 18, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 15, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 25, 2022 | Feb 18, 2022 |
| 4 | Insider transaction | Feb 22, 2022 | Feb 18, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.